Education
About Us
Working with TipRanks
Follow Us
Pds Biotechnology (PDSB)
:PDSB
Total Valuation
PDS Biotechnology has a market cap or net worth of $71.31M. The enterprise value is -$39.80B.
Market Cap$71.31M
Enterprise Value-$39.80B
Share Statistics
PDS Biotechnology has 45,710,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding45,710,000
Owned by Insiders1.31%
Owned by Institutions10.16%
Financial Efficiency
PDS Biotechnology’s return on equity (ROE) is -2.07 and return on invested capital (ROIC) is -90960.74%.
Return on Equity (ROE)-2.07
Return on Assets (ROA)-867.50
Return on Invested Capital (ROIC)-90960.74%
Return on Capital Employed (ROCE)-1.28K
Revenue Per Employee0.00
Profits Per Employee-1.57M
Employee Count24
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of PDS Biotechnology is >-0.01. PDS Biotechnology’s PEG ratio is >-0.01.
PE Ratio>-0.01
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio>-0.01
Income Statement
In the last 12 months, PDS Biotechnology had revenue of 0.00 and earned -37.61M in profits. Earnings per share was -1.08K.
Revenue0.00
Gross Profit-59.79K
Operating Income-36.32M
Pretax Income-38.48M
Net Income-37.61M
EBITDA-33.75M
Earnings Per Share (EPS)-1.08K
Cash Flow
In the last 12 months, operating cash flow was -34.12M and capital expenditures -29.00K, giving a free cash flow of -34.15M billion.
Operating Cash Flow-34.12M
Free Cash Flow-34.15M
Free Cash Flow per Share-0.75
Dividends & Yields
PDS Biotechnology pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.42
52-Week Price Change-40.07%
50-Day Moving Average1.27
200-Day Moving Average2.03
Relative Strength Index (RSI)64.38
Average Volume (3m)599.57K
Important Dates
PDS Biotechnology upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend Date―
Financial Position
PDS Biotechnology as a current ratio of 2.64, with Debt / Equity ratio of 0.48%
Current Ratio2.64
Quick Ratio2.64
Debt to Market Cap0.37
Net Debt to EBITDA<0.01
Interest Coverage Ratio-7.77K
Taxes
In the past 12 months, PDS Biotechnology has paid -869.00K in taxes.
Income Tax-869.00K
Effective Tax Rate-0.02
Enterprise Valuation
PDS Biotechnology EV to EBITDA ratio is >-0.01, with an EV/FCF ratio of -1.13.
EV to Sales0.00
EV to EBITDA>-0.01
EV to Free Cash Flow-1.13
EV to Operating Cash Flow-1.13
Balance Sheet
PDS Biotechnology has $39.98M in cash and marketable securities with $18.96M in debt, giving a net cash position of -$21.02M billion.
Cash & Marketable Securities$39.98M
Total Debt$18.96M
Net Cash-$21.02M
Net Cash Per Share-$0.46
Tangible Book Value Per Share$0.52
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for PDS Biotechnology is $7.50, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$7.50
Price Target Upside343.79% Upside
Analyst ConsensusStrong Buy
Analyst Count3
Revenue Growth Forecast―
EPS Growth Forecast25.51%